Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129:e521-e643.
Lancellotti P, Tribouilloy C, Hagendorff A, et al. European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 1: aortic and pulmonary regurgitation (native valve disease). Eur J Echocardiogr. 2010;11:223-244.
Zoghbi WA, Enriquez-Sarano M, Foster E, et al. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr. 2003;16:777-802.
Bonow RO, Lakatos E, Maron BJ, et al. Serial long-term assessment of the natural history of asymptomatic patients with chronic aortic regurgitation and normal left ventricular systolic function. Circulation. 1991;84:1625-1635.
Dujardin KS, Enriquez-Sarano M, Schaff HV, et al. Mortality and morbidity of aortic regurgitation in clinical practice: a long-term follow-up study. Circulation. 1999;99:1851-1857.
1. Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129:e521-e643.
2. Gaasch WH, Sundaram M, Meyer TE. Managing asymptomatic patients with chronic aortic regurgitation. Chest. 1997;111:1702-1709.
3. Henry WL, Bonow RO, Rosing DR, et al. Observations on the optimum time for operative intervention for aortic regurgitation. II. Serial echocardiographic evaluation of asymptomatic patients. Circulation. 1980; 61:484-492.
4. Fox ER, Wilson RS, Penman AD, et al. Epidemiology of pure valvular regurgitation in the large middle-aged African American cohort of the Atherosclerosis Risk in Communities study. Am Heart J. 2007;154:1229-1234.
5. Singh JP, Evans JC, Levy D, et al. Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study). Am J Cardiol. 1999;83:897-902.
6. Lindroos M, Kupari M, Heikkila J, et al. Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol. 1993;21:1220-1225.
7. Reid CL, Anton-Culver H, Yunis C, et al. Prevalence and clinical correlates of isolated mitral, isolated aortic regurgitation, and both in adults aged 21 to 35 years (from the CARDIA study). Am J Cardiol. 2007;99:830-834.
8. Griffin FM Jr, Jones G, Cobbs CC. Aortic insufficiency in bacterial endocarditis. Ann Intern Med. 1972;76:23-28.
9. Roberts WC, Ko JM, Moore TR, et al. Causes of pure aortic regurgitation in patients having isolated aortic valve replacement at a single US tertiary hospital (1993 to 2005). Circulation. 2006;114:422-429.
10. Kim M, Roman MJ, Cavallini MC, et al. Effect of hypertension on aortic root size and prevalence of aortic regurgitation. Hypertension. 1996;28:47-52.
11. Braunwald E, Zipes DP, Libby P. Heart disease: a textbook of cardiovascular medicine. 6th ed. Philadelphia: WB Saunders; 2001.
12. Roberts WC, Morrow AG, McIntosh CL, et al. Congenitally bicuspid aortic valve causing severe, pure aortic regurgitation without superimposed infective endocarditis: analysis of 13 patients requiring aortic valve replacement. Am J Cardiol. 1981;47:206-209.
13. Brown OR, DeMots H, Kloster FE, et al. Aortic root dilatation and mitral valve prolapse in Marfan's syndrome: an echocardiographic study. Circulation. 1975;52:651-657.
14. Bulkley BH, Roberts WC. Ankylosing spondylitis and aortic regurgitation: description of the characteristic cardiovascular lesion from study of eight necropsy patients. Circulation. 1973;48:1014-1027.
15. Lancellotti P, Tribouilloy C, Hagendorff A, et al. European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 1: aortic and pulmonary regurgitation (native valve disease). Eur J Echocardiogr. 2010;11:223-244.
16. Saura D, López-Cuenca A, Oliva MJ, et al. Accuracy of systolic aortic regurgitation in the diagnosis of heart failure: a predictive approach. Int J Clin Pract. 2015;69:485-490.
17. Babu AN, Kymes SM, Carpenter Fryer SM. Eponyms and the diagnosis of aortic regurgitation: what says the evidence? Ann Intern Med. 2003;138:736-742.
18. Shindler DM. Practical cardiac auscultation. Crit Care Nurs Q. 2007;30:166-180.
19. Landzberg JS, Pflugfelder PW, Cassidy MM. et al. Etiology of the Austin Flint murmur. J Am Coll Cardiol. 1992;20:408-413.
20. Choudhry NK, Etchells EE. The rational clinical examination: does this patient have aortic regurgitation? JAMA. 1999;281:2231-2238.
21. Zoghbi WA, Enriquez-Sarano M, Foster E, et al. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr. 2003;16:777-802.
22. Bonow RO. Radionuclide angiography in the management of asymptomatic aortic regurgitation. Circulation. 1991;84(3 Suppl):I296-302.
23. Shah RM, Singh M, Bhuriya R, et al. Favorable effects of vasodilators on left ventricular remodeling in asymptomatic patients with chronic moderate-severe aortic regurgitation and normal ejection fraction: a meta-analysis of clinical trials. Clin Cardiol. 2012;35:619-625.
24. Mahajerin A, Gurm HS, Tsai TT, et al . Vasodilator therapy in patients with aortic insufficiency: a systematic review. Am Heart J. 2007;153:454-461.
25. Tommaso CL, Bolman RM 3rd, Feldman T, et al. Multisociety (AATS, ACCF, SCAI, and STS) expert consensus statement: operator and institutional requirements for transcatheter valve repair and replacement, part 1: transcatheter aortic valve replacement. J Thorac Cardiovasc Surg. 2012;143:1254-1263.
26. Gaasch WH, Andrias CW, Levine HJ. Chronic aortic regurgitation: the effect of aortic valve replacement on left ventricular volume, mass and function. Circulation. 1978;58:825-836.
27. Bonow RO, Dodd JT, Maron BJ, et al. Long-term serial changes in left ventricular function and reversal of ventricular dilatation after valve replacement for chronic aortic regurgitation. Circulation. 1988;78:1108-1120.
28. Bonow RO, Picone AL, McIntosh CL, et al. Survival and functional results after valve replacement for aortic regurgitation from 1976 to 1983: impact of preoperative left ventricular function. Circulation. 1985;72:1244-1256.
29. Mahajerin A, Gurm HS, Tsai TT, et al. Vasodilator therapy in patients with aortic insufficiency: a systematic review. Am Heart J. 2007;153:454-461.
30. Scognamiglio R, Rahimtoola SH, Fasoli G, et al. Nifedipine in asymptomatic patients with severe aortic regurgitation and normal left ventricular function. N Engl J Med. 1994;331:689-694.
31. Evangelista A, Tornos P, Sambola A, et al. Long-term vasodilator therapy in patients with severe aortic regurgitation. N Engl J Med. 2005;353:1342-1349.
32. Kleaveland JP, Reichek N, McCarthy DM, et al. Effects of six-month afterload reduction therapy with hydralazine in chronic aortic regurgitation. Am J Cardiol. 1986;57:1109-1116.
33. Greenberg B, Massie B, Bristow JD, et al. Long-term vasodilator therapy of chronic aortic insufficiency: a randomized double-blinded, placebo-controlled clinical trial. Circulation. 1988;78:92-103.
34. Bonow RO, Rosing DR, McIntosh CL, et al. The natural history of asymptomatic patients with aortic regurgitation and normal left ventricular function. Circulation. 1983;68:509-517.
35. Bonow RO, Lakatos E, Maron BJ, et al. Serial long-term assessment of the natural history of asymptomatic patients with chronic aortic regurgitation and normal left ventricular systolic function. Circulation. 1991;84:1625-1635.
36. Dujardin KS, Enriquez-Sarano M, Schaff HV, et al. Mortality and morbidity of aortic regurgitation in clinical practice: a long-term follow-up study. Circulation. 1999;99:1851-1857.
37. Wilson W, Taubert KA, Gewitz M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association. J Am Dent Assoc. 2007;138:739-745.
38. Alexopoulos D, Kolovou G, Kyriakidis M, et al. Angina and coronary artery disease in patients with aortic valve disease. Angiology. 1993;44:707-11.
39. Pathak R, Padmanabhan VT, Tortolani AJ, et al. Angina pectoris and coronary artery disease in isolated, severe aortic regurgitation. Am J Cardiol. 1986;57:649-651.
40. Edwards FH, Peterson ED, Coombs LP, et al. Prediction of operative mortality after valve replacement surgery. J Am Coll of Cardiol. 2001;37:885-892.
41. Bonow RO, Cheitlin MD, Crawford MH, et al. Task Force 3: valvular heart disease. J Am Coll Cardiol. 2005;45:1334-1340.
使用此内容应接受我们的免责声明。
BMJ临床实践的持续改进离不开您的帮助和反馈。如果您发现任何功能问题和内容错误,或您对BMJ临床实践有任何疑问或建议,请您扫描右侧二维码并根据页面指导填写您的反馈和联系信息*。一旦您的建议在我们核实后被采纳,您将会收到一份小礼品。
如果您有紧急问题需要我们帮助,请您联系我们。
邮箱:bmjchina.support@bmj.com
电话:+86 10 64100686-612
*您的联系信息仅会用于我们与您确认反馈信息和礼品事宜。
BMJ临床实践官方反馈平台